Healthlinx Ltd (HTX.AX)

HTX.AX on Australia Stock Exchange

0.00AUD
1 Mar 2013
Price Change (% chg)

$-0.00 (-50.00%)
Prev Close
$0.00
Open
$0.00
Day's High
$0.00
Day's Low
$0.00
Volume
670,000
Avg. Vol
7,814,832
52-wk High
$0.01
52-wk Low
$0.00

HTX.AX

Chart for HTX.AX

About

Healthlinx Limited is an Australia-based company operating in three segments: Cryptomics, Diagnostics, and Peptide Research. The Company’s principal activities include finalization of the clinical validation of OvPlex; expanding distribution channels for OvPlex through agreements for Spain and Portugal, Malaysia and India; the... (more)
No analyst recommendations are available for HTX.AX.

Overall

Beta: 2.00
Market Cap (Mil.): $0.03
Shares Outstanding (Mil.): 27.77
Dividend: --
Yield (%): --

Financials

  HTX.AX Industry Sector
P/E (TTM): -- 60.01 35.83
EPS (TTM): -0.86 -- --
ROI: -- 6.11 18.29
ROE: -- 9.57 19.18
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00
Provider: GlobalData
$250.00
Provider: Wright Reports
$403.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks